Application YC di Guardian Bio

Summer 2022Active

Guardian Bio ha partecipato a Y Combinator nel batch Summer 2022 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Summer 2022
Settore: HealthcareTherapeutics
Dimensione team: 2
Stato: Active
Lanciata: 2022

Founder

Ananya ZutshiFounder
Ricky BarrettFounder

Cosa fa Guardian Bio

Your immune system is your body’s best weapon and defense against cancer. It is only when it is overcome that cancer develops into full blown disease. Dendritic cells sit at the helm of the immune system, directing and dictating immune responses. Data has shown dendritic cells are often dysfunctional in cancer patients, and that this dysfunction is a bottleneck for other therapies. Guardian Bio’s approach is focused on creating a dendritic cell-based product which drives anti-tumor activity through activating the killers of the immune system AND training them against multiple cancer targets. We take stem cells from cancer patients, turn them into specific therapeutic dendritic cells specially trained against that patient’s tumor, and re-introduce them back into the body. Our therapeutic dendritic cells revitalize the killers of the immune system and give them the kickstart they need to fight - and win - against cancer.

Application YC di Guardian Bio, ricostruita

Domanda per Y Combinator

Guardian Bio, batch Summer 2022. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Guardian Bio

Describe what your company does in 50 characters or less.

Dendritic cell-based platform for cancer therapy

What is your company going to make? Please describe your product and what it does or will do.

We create a dendritic cell therapy for cancer patients. Our product takes stem cells from a patient, turns them into therapeutic dendritic cells trained to recognize that patient's tumor, and puts them back to activate the immune system to fight cancer.

Where do you live now, and where would the company be based after YC?

We currently live in Boston, MA, and the company will be based there after YC as well.

Explain your decision regarding location.

Boston is a hub for biotech and medical research with access to leading hospitals and academic collaborators, which is critical for our work developing cellular therapies.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Guardian Bio?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Guardian Bio (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Guardian Bio si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Guardian Bio?

Guardian Bio apparteneva al batch Summer 2022 di Y Combinator.

Chi ha fondato Guardian Bio?

Guardian Bio è stato fondato da Ananya Zutshi, Ricky Barrett.

Cosa fa Guardian Bio?

Dendritic cell-based platform for cancer therapy

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Guardian Bio, e di ogni altro batch YC, è in YC Insights.